Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody
Crossref DOI link: https://doi.org/10.1007/s00262-017-2092-x
Published Online: 2017-12-04
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suh, Koung Jin
Kim, Se Hyun
Kim, Yu Jung
Kim, Miso
Keam, Bhumsuk
Kim, Tae Min
Kim, Dong-Wan
Heo, Dae Seog
Lee, Jong Seok
License valid from 2017-12-04